Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.14698310 |
2 | synaptic vesicle maturation (GO:0016188) | 4.84869317 |
3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.73356140 |
4 | synaptic vesicle exocytosis (GO:0016079) | 4.61436185 |
5 | locomotory exploration behavior (GO:0035641) | 4.58440330 |
6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.53282636 |
7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.45292772 |
8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.35816314 |
9 | cellular potassium ion homeostasis (GO:0030007) | 4.33402913 |
10 | glutamate secretion (GO:0014047) | 4.31243817 |
11 | vocalization behavior (GO:0071625) | 4.09604513 |
12 | regulation of synaptic vesicle transport (GO:1902803) | 4.04005873 |
13 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.99571933 |
14 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.93391014 |
15 | creatine metabolic process (GO:0006600) | 3.88249765 |
16 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.87314986 |
17 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.83331486 |
18 | neurotransmitter secretion (GO:0007269) | 3.80530714 |
19 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.77459087 |
20 | cell communication by electrical coupling (GO:0010644) | 3.76159425 |
21 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.71781224 |
22 | protein localization to synapse (GO:0035418) | 3.69290436 |
23 | muscle filament sliding (GO:0030049) | 3.65715205 |
24 | actin-myosin filament sliding (GO:0033275) | 3.65715205 |
25 | sodium ion export (GO:0071436) | 3.59128216 |
26 | response to pheromone (GO:0019236) | 3.54423564 |
27 | cardiac muscle contraction (GO:0060048) | 3.50900216 |
28 | regulation of synapse structural plasticity (GO:0051823) | 3.48780353 |
29 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.48064823 |
30 | synaptic transmission, glutamatergic (GO:0035249) | 3.47015964 |
31 | neuronal action potential propagation (GO:0019227) | 3.43304354 |
32 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.43142277 |
33 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.43068568 |
34 | cerebellar granule cell differentiation (GO:0021707) | 3.41456005 |
35 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.38099695 |
36 | striated muscle contraction (GO:0006941) | 3.34677696 |
37 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.33915542 |
38 | glutamate receptor signaling pathway (GO:0007215) | 3.32971848 |
39 | exploration behavior (GO:0035640) | 3.32686047 |
40 | layer formation in cerebral cortex (GO:0021819) | 3.32397520 |
41 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.29533334 |
42 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.29419365 |
43 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.28424270 |
44 | synaptic vesicle endocytosis (GO:0048488) | 3.27889251 |
45 | long-term memory (GO:0007616) | 3.27158056 |
46 | alanine transport (GO:0032328) | 3.25986259 |
47 | neuron-neuron synaptic transmission (GO:0007270) | 3.25037484 |
48 | positive regulation of synapse maturation (GO:0090129) | 3.23524772 |
49 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.22536345 |
50 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.21161174 |
51 | myofibril assembly (GO:0030239) | 3.19985271 |
52 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.19381534 |
53 | neuron cell-cell adhesion (GO:0007158) | 3.19146438 |
54 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.19025859 |
55 | potassium ion homeostasis (GO:0055075) | 3.16291202 |
56 | regulation of relaxation of muscle (GO:1901077) | 3.16202962 |
57 | gamma-aminobutyric acid transport (GO:0015812) | 3.11889669 |
58 | innervation (GO:0060384) | 3.10563930 |
59 | neurotransmitter transport (GO:0006836) | 3.10217047 |
60 | proline transport (GO:0015824) | 3.09986124 |
61 | regulation of cell communication by electrical coupling (GO:0010649) | 3.09803863 |
62 | skeletal muscle contraction (GO:0003009) | 3.08984907 |
63 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.07989102 |
64 | membrane depolarization during action potential (GO:0086010) | 3.06859103 |
65 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.05450791 |
66 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.01980124 |
67 | detection of calcium ion (GO:0005513) | 3.01522479 |
68 | regulation of neurotransmitter secretion (GO:0046928) | 3.00099205 |
69 | activation of protein kinase A activity (GO:0034199) | 2.99735481 |
70 | positive regulation of membrane potential (GO:0045838) | 2.99239170 |
71 | cellular sodium ion homeostasis (GO:0006883) | 2.99215652 |
72 | ethanol oxidation (GO:0006069) | 2.98265524 |
73 | regulation of actin filament-based movement (GO:1903115) | 2.97742119 |
74 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.95800301 |
75 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.94725570 |
76 | long-term synaptic potentiation (GO:0060291) | 2.94561005 |
77 | long term synaptic depression (GO:0060292) | 2.94449532 |
78 | regulation of vesicle fusion (GO:0031338) | 2.93681860 |
79 | dendritic spine morphogenesis (GO:0060997) | 2.92231574 |
80 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.90904780 |
81 | cardiac muscle hypertrophy (GO:0003300) | 2.90414621 |
82 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.87265879 |
83 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.86664583 |
84 | glycine transport (GO:0015816) | 2.86306624 |
85 | regulation of postsynaptic membrane potential (GO:0060078) | 2.85989084 |
86 | regulation of neurotransmitter levels (GO:0001505) | 2.85189381 |
87 | response to auditory stimulus (GO:0010996) | 2.84484164 |
88 | actin-mediated cell contraction (GO:0070252) | 2.84341751 |
89 | regulation of synaptic plasticity (GO:0048167) | 2.83838747 |
90 | striated muscle hypertrophy (GO:0014897) | 2.81222792 |
91 | cardiac myofibril assembly (GO:0055003) | 2.80246765 |
92 | regulation of neurotransmitter transport (GO:0051588) | 2.80087747 |
93 | NADH metabolic process (GO:0006734) | 2.79392131 |
94 | L-amino acid import (GO:0043092) | 2.78520927 |
95 | synapse assembly (GO:0007416) | 2.78026608 |
96 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.77854859 |
97 | cell communication involved in cardiac conduction (GO:0086065) | 2.76399210 |
98 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.75746914 |
99 | membrane hyperpolarization (GO:0060081) | 2.74909731 |
100 | neuromuscular process controlling posture (GO:0050884) | 2.74783640 |
101 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.74673402 |
102 | regulation of ARF protein signal transduction (GO:0032012) | 2.73223746 |
103 | potassium ion import (GO:0010107) | 2.69894454 |
104 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.69890664 |
105 | positive regulation of neurotransmitter transport (GO:0051590) | 2.69508022 |
106 | chemosensory behavior (GO:0007635) | 2.67586817 |
107 | 2-oxoglutarate metabolic process (GO:0006103) | 2.67272929 |
108 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.67096661 |
109 | muscle hypertrophy in response to stress (GO:0003299) | 2.67096661 |
110 | cardiac muscle adaptation (GO:0014887) | 2.67096661 |
111 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.66840445 |
112 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.65523713 |
113 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.64755911 |
114 | dendrite morphogenesis (GO:0048813) | 2.64636393 |
115 | auditory behavior (GO:0031223) | 2.64615437 |
116 | prepulse inhibition (GO:0060134) | 2.63420939 |
117 | transmission of nerve impulse (GO:0019226) | 2.63338094 |
118 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.62057005 |
119 | positive regulation of dendritic spine development (GO:0060999) | 2.61521680 |
120 | positive regulation of synaptic transmission (GO:0050806) | 2.60461985 |
121 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.60376695 |
122 | muscle hypertrophy (GO:0014896) | 2.59912354 |
123 | membrane depolarization (GO:0051899) | 2.59698171 |
124 | striatum development (GO:0021756) | 2.59031699 |
125 | behavioral response to cocaine (GO:0048148) | 2.58887155 |
126 | regulation of synapse maturation (GO:0090128) | 2.58875968 |
127 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.58407657 |
128 | regulation of skeletal muscle contraction (GO:0014819) | 2.56545289 |
129 | neuromuscular process controlling balance (GO:0050885) | 2.56380944 |
130 | sarcomere organization (GO:0045214) | 2.55428411 |
131 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.55324085 |
132 | regulation of membrane repolarization (GO:0060306) | 2.54482166 |
133 | urinary tract smooth muscle contraction (GO:0014848) | 2.53258085 |
134 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.52954783 |
135 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.52954783 |
136 | synaptic transmission (GO:0007268) | 2.52579599 |
137 | amino acid import (GO:0043090) | 2.52055740 |
138 | macroautophagy (GO:0016236) | 2.52022881 |
139 | cellular response to epinephrine stimulus (GO:0071872) | 2.49205410 |
140 | ethanol metabolic process (GO:0006067) | 2.47204317 |
141 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.43207981 |
142 | striated muscle adaptation (GO:0014888) | 2.42327988 |
143 | regulation of sequestering of triglyceride (GO:0010889) | 2.39776500 |
144 | neuronal ion channel clustering (GO:0045161) | 2.39655914 |
145 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.37027282 |
146 | carnitine shuttle (GO:0006853) | 2.36325573 |
147 | actin filament-based movement (GO:0030048) | 2.35369001 |
148 | response to mercury ion (GO:0046689) | 2.33761348 |
149 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.31399265 |
150 | skeletal muscle adaptation (GO:0043501) | 2.30338827 |
151 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.30296320 |
152 | complement activation, alternative pathway (GO:0006957) | 2.28790997 |
153 | muscle contraction (GO:0006936) | 2.28680971 |
154 | cellular response to catecholamine stimulus (GO:0071870) | 2.28070615 |
155 | cellular response to monoamine stimulus (GO:0071868) | 2.28070615 |
156 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.27915483 |
157 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.27241367 |
158 | oxaloacetate metabolic process (GO:0006107) | 2.24651974 |
159 | fatty acid transmembrane transport (GO:1902001) | 2.23789616 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.89250521 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.26510125 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.82077999 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.76994783 |
5 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.64664430 |
6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.61003601 |
7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.53580399 |
8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.47756941 |
9 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.43915756 |
10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.38051745 |
11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.38051745 |
12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.36777594 |
13 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.32253815 |
14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.31602950 |
15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.29789293 |
16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.25014210 |
17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.21799086 |
18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.18892922 |
19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.18013081 |
20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.14098156 |
21 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.12307553 |
22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.09770109 |
23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.00587604 |
24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.91154135 |
25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.87429322 |
26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.85148721 |
27 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.73915268 |
28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.68506131 |
29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.68104821 |
30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.67882805 |
31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.64128551 |
32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.63083519 |
33 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.59640332 |
34 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.57105072 |
35 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.55422830 |
36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.52296124 |
37 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.49396653 |
38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.49379711 |
39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.48335650 |
40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.48269459 |
41 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.47622953 |
42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40443981 |
43 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.39133892 |
44 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.36329699 |
45 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.35694085 |
46 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.35694085 |
47 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.33892262 |
48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.33092154 |
49 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.33079718 |
50 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.32532333 |
51 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29445488 |
52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29366851 |
53 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.29257156 |
54 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.28964801 |
55 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28638411 |
56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27760719 |
57 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.25463240 |
58 | AR_19668381_ChIP-Seq_PC3_Human | 1.24998428 |
59 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.23606877 |
60 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22450413 |
61 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21825592 |
62 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.21532335 |
63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18875458 |
64 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.16068902 |
65 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.15707488 |
66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14699684 |
67 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14676010 |
68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14387467 |
69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13879807 |
70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.13627277 |
71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.13477858 |
72 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.13250047 |
73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.12509011 |
74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.12225590 |
75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11516201 |
76 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.09494704 |
77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08278103 |
78 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07457772 |
79 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.05969264 |
80 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.05188443 |
81 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04518867 |
82 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.04332446 |
83 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04324000 |
84 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.03240952 |
85 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.02866905 |
86 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.02632641 |
87 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.02505527 |
88 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.02369486 |
89 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02205757 |
90 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01977155 |
91 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.01175021 |
92 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01061870 |
93 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00757399 |
94 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00558279 |
95 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00263258 |
96 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99724726 |
97 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99678103 |
98 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.98898223 |
99 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98869045 |
100 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.97808313 |
101 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97706850 |
102 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.97531579 |
103 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97013441 |
104 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.96284094 |
105 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.96073907 |
106 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.95878797 |
107 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95440897 |
108 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94810053 |
109 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.94705810 |
110 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.94679543 |
111 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94289835 |
112 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93949357 |
113 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93733147 |
114 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93292949 |
115 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93089808 |
116 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.92602286 |
117 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.92596028 |
118 | * P68_20966046_ChIP-Seq_HELA_Human | 0.92217411 |
119 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.91266236 |
120 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.91116739 |
121 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91060287 |
122 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.90956951 |
123 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90798204 |
124 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.90736035 |
125 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.90578978 |
126 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.89305210 |
127 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.88924910 |
128 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88720314 |
129 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88690550 |
130 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.88215921 |
131 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.87228918 |
132 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86923209 |
133 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86878047 |
134 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86317492 |
135 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.85551544 |
136 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.84926323 |
137 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84231636 |
138 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.83915105 |
139 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83783471 |
140 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.83493612 |
141 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.82924078 |
142 | RXR_22108803_ChIP-Seq_LS180_Human | 0.81055489 |
143 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.80937472 |
144 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.80327026 |
145 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.80208502 |
146 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.79959456 |
147 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.79273912 |
148 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.79061032 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.12772389 |
2 | MP0003635_abnormal_synaptic_transmissio | 3.45347704 |
3 | MP0003880_abnormal_central_pattern | 3.32907784 |
4 | MP0004270_analgesia | 3.13287999 |
5 | MP0002822_catalepsy | 2.83004559 |
6 | MP0009745_abnormal_behavioral_response | 2.74750748 |
7 | MP0002063_abnormal_learning/memory/cond | 2.72743641 |
8 | MP0009780_abnormal_chondrocyte_physiolo | 2.64302759 |
9 | MP0002909_abnormal_adrenal_gland | 2.57570081 |
10 | MP0009046_muscle_twitch | 2.57167645 |
11 | MP0002064_seizures | 2.56526339 |
12 | MP0003646_muscle_fatigue | 2.55618868 |
13 | MP0001968_abnormal_touch/_nociception | 2.39317927 |
14 | MP0002572_abnormal_emotion/affect_behav | 2.38658059 |
15 | MP0002272_abnormal_nervous_system | 2.27956856 |
16 | MP0000749_muscle_degeneration | 2.26992369 |
17 | MP0001486_abnormal_startle_reflex | 2.26177376 |
18 | MP0002734_abnormal_mechanical_nocicepti | 2.22827054 |
19 | MP0001984_abnormal_olfaction | 2.20012901 |
20 | MP0005646_abnormal_pituitary_gland | 2.19113464 |
21 | MP0005423_abnormal_somatic_nervous | 2.17903535 |
22 | MP0001501_abnormal_sleep_pattern | 1.99148721 |
23 | MP0004510_myositis | 1.98645570 |
24 | MP0004858_abnormal_nervous_system | 1.97776903 |
25 | MP0004087_abnormal_muscle_fiber | 1.91162849 |
26 | MP0002332_abnormal_exercise_endurance | 1.88733363 |
27 | MP0005551_abnormal_eye_electrophysiolog | 1.85876626 |
28 | MP0003329_amyloid_beta_deposits | 1.84050398 |
29 | MP0003879_abnormal_hair_cell | 1.81427531 |
30 | MP0001440_abnormal_grooming_behavior | 1.80885253 |
31 | MP0004084_abnormal_cardiac_muscle | 1.80727479 |
32 | MP0002736_abnormal_nociception_after | 1.80329148 |
33 | MP0000747_muscle_weakness | 1.79186976 |
34 | MP0005645_abnormal_hypothalamus_physiol | 1.78293091 |
35 | MP0002106_abnormal_muscle_physiology | 1.76919236 |
36 | MP0008569_lethality_at_weaning | 1.73659881 |
37 | MP0002733_abnormal_thermal_nociception | 1.73330574 |
38 | * MP0001502_abnormal_circadian_rhythm | 1.72013734 |
39 | MP0000013_abnormal_adipose_tissue | 1.71102135 |
40 | MP0000759_abnormal_skeletal_muscle | 1.68711802 |
41 | MP0002067_abnormal_sensory_capabilities | 1.67664197 |
42 | MP0002735_abnormal_chemical_nociception | 1.66294551 |
43 | MP0010386_abnormal_urinary_bladder | 1.65751908 |
44 | MP0002837_dystrophic_cardiac_calcinosis | 1.63455608 |
45 | MP0002557_abnormal_social/conspecific_i | 1.62162536 |
46 | MP0005451_abnormal_body_composition | 1.60690582 |
47 | MP0002971_abnormal_brown_adipose | 1.58496069 |
48 | MP0001970_abnormal_pain_threshold | 1.56630795 |
49 | MP0005620_abnormal_muscle_contractility | 1.56176430 |
50 | MP0002184_abnormal_innervation | 1.53880843 |
51 | MP0006276_abnormal_autonomic_nervous | 1.53421905 |
52 | MP0005369_muscle_phenotype | 1.53174367 |
53 | MP0005386_behavior/neurological_phenoty | 1.51533929 |
54 | MP0004924_abnormal_behavior | 1.51533929 |
55 | MP0005666_abnormal_adipose_tissue | 1.49748235 |
56 | MP0002972_abnormal_cardiac_muscle | 1.48134180 |
57 | MP0004484_altered_response_of | 1.47363400 |
58 | MP0002269_muscular_atrophy | 1.41017318 |
59 | MP0004885_abnormal_endolymph | 1.37629917 |
60 | MP0005375_adipose_tissue_phenotype | 1.35273784 |
61 | MP0004043_abnormal_pH_regulation | 1.33861351 |
62 | MP0002090_abnormal_vision | 1.32915338 |
63 | MP0008961_abnormal_basal_metabolism | 1.32141318 |
64 | MP0000750_abnormal_muscle_regeneration | 1.31338305 |
65 | MP0003633_abnormal_nervous_system | 1.31257464 |
66 | MP0005330_cardiomyopathy | 1.31176269 |
67 | MP0004145_abnormal_muscle_electrophysio | 1.30107844 |
68 | MP0004811_abnormal_neuron_physiology | 1.28935581 |
69 | MP0000955_abnormal_spinal_cord | 1.28898380 |
70 | MP0005365_abnormal_bile_salt | 1.21853002 |
71 | MP0006138_congestive_heart_failure | 1.21680319 |
72 | MP0000751_myopathy | 1.20395958 |
73 | MP0004233_abnormal_muscle_weight | 1.19521832 |
74 | MP0002882_abnormal_neuron_morphology | 1.19384395 |
75 | MP0006072_abnormal_retinal_apoptosis | 1.19225891 |
76 | MP0008875_abnormal_xenobiotic_pharmacok | 1.18067368 |
77 | MP0002066_abnormal_motor_capabilities/c | 1.16477685 |
78 | MP0005167_abnormal_blood-brain_barrier | 1.14712472 |
79 | MP0003183_abnormal_peptide_metabolism | 1.14494675 |
80 | MP0005535_abnormal_body_temperature | 1.11777056 |
81 | MP0003195_calcinosis | 1.09489572 |
82 | MP0002108_abnormal_muscle_morphology | 1.08288381 |
83 | MP0003283_abnormal_digestive_organ | 1.07999417 |
84 | MP0002229_neurodegeneration | 1.07974432 |
85 | MP0009840_abnormal_foam_cell | 1.07007041 |
86 | MP0003122_maternal_imprinting | 1.06472408 |
87 | MP0004215_abnormal_myocardial_fiber | 1.05836737 |
88 | MP0010630_abnormal_cardiac_muscle | 1.05649877 |
89 | MP0002139_abnormal_hepatobiliary_system | 1.03301652 |
90 | MP0001544_abnormal_cardiovascular_syste | 1.03140592 |
91 | MP0005385_cardiovascular_system_phenoty | 1.03140592 |
92 | MP0000920_abnormal_myelination | 1.02311091 |
93 | MP0000778_abnormal_nervous_system | 1.02103869 |
94 | MP0006292_abnormal_olfactory_placode | 1.01192682 |
95 | MP0002069_abnormal_eating/drinking_beha | 1.01000312 |
96 | MP0004142_abnormal_muscle_tone | 0.99694852 |
97 | MP0001529_abnormal_vocalization | 0.97993803 |
98 | MP0003631_nervous_system_phenotype | 0.97701323 |
99 | MP0004085_abnormal_heartbeat | 0.96912619 |
100 | MP0003787_abnormal_imprinting | 0.96599205 |
101 | MP0002118_abnormal_lipid_homeostasis | 0.96069786 |
102 | MP0005253_abnormal_eye_physiology | 0.95861920 |
103 | MP0005670_abnormal_white_adipose | 0.95800981 |
104 | MP0003868_abnormal_feces_composition | 0.94815642 |
105 | MP0002078_abnormal_glucose_homeostasis | 0.92243150 |
106 | MP0002234_abnormal_pharynx_morphology | 0.91005921 |
107 | MP0003303_peritoneal_inflammation | 0.90465471 |
108 | MP0005379_endocrine/exocrine_gland_phen | 0.89409016 |
109 | MP0010329_abnormal_lipoprotein_level | 0.89170450 |
110 | MP0004130_abnormal_muscle_cell | 0.88931188 |
111 | MP0000631_abnormal_neuroendocrine_gland | 0.86932912 |
112 | MP0003690_abnormal_glial_cell | 0.86241711 |
113 | MP0001944_abnormal_pancreas_morphology | 0.85517662 |
114 | MP0004036_abnormal_muscle_relaxation | 0.82627497 |
115 | MP0000003_abnormal_adipose_tissue | 0.82386176 |
116 | MP0003045_fibrosis | 0.82206137 |
117 | MP0002152_abnormal_brain_morphology | 0.81771738 |
118 | MP0003137_abnormal_impulse_conducting | 0.81694826 |
119 | MP0003191_abnormal_cellular_cholesterol | 0.80295527 |
120 | MP0005085_abnormal_gallbladder_physiolo | 0.79832002 |
121 | MP0003634_abnormal_glial_cell | 0.79241785 |
122 | MP0000604_amyloidosis | 0.78663475 |
123 | MP0005448_abnormal_energy_balance | 0.77014551 |
124 | MP0003828_pulmonary_edema | 0.76952225 |
125 | MP0001177_atelectasis | 0.76812863 |
126 | * MP0002638_abnormal_pupillary_reflex | 0.75886505 |
127 | MP0002876_abnormal_thyroid_physiology | 0.75653852 |
128 | MP0008872_abnormal_physiological_respon | 0.75017987 |
129 | MP0003075_altered_response_to | 0.75001295 |
130 | MP0005334_abnormal_fat_pad | 0.74907603 |
131 | MP0008874_decreased_physiological_sensi | 0.74630982 |
132 | MP0005409_darkened_coat_color | 0.74556642 |
133 | MP0000678_abnormal_parathyroid_gland | 0.74424273 |
134 | MP0003953_abnormal_hormone_level | 0.74379897 |
135 | MP0002693_abnormal_pancreas_physiology | 0.73360524 |
136 | MP0009115_abnormal_fat_cell | 0.73035255 |
137 | MP0001188_hyperpigmentation | 0.72558107 |
138 | MP0005166_decreased_susceptibility_to | 0.69973865 |
139 | MP0001905_abnormal_dopamine_level | 0.68946235 |
140 | MP0003656_abnormal_erythrocyte_physiolo | 0.68630269 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 5.59553204 |
2 | Myokymia (HP:0002411) | 5.03450949 |
3 | Muscle fiber inclusion bodies (HP:0100299) | 4.95674275 |
4 | Nemaline bodies (HP:0003798) | 4.75972645 |
5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.74984141 |
6 | Muscle fiber splitting (HP:0003555) | 4.63003470 |
7 | Visual hallucinations (HP:0002367) | 4.51567986 |
8 | Type 1 muscle fiber predominance (HP:0003803) | 4.42286042 |
9 | Epileptic encephalopathy (HP:0200134) | 4.37013551 |
10 | Focal seizures (HP:0007359) | 4.21416134 |
11 | Hyporeflexia of lower limbs (HP:0002600) | 3.94019270 |
12 | Febrile seizures (HP:0002373) | 3.78270330 |
13 | Progressive cerebellar ataxia (HP:0002073) | 3.68274872 |
14 | Sudden death (HP:0001699) | 3.67830712 |
15 | EMG: myopathic abnormalities (HP:0003458) | 3.55616744 |
16 | Absence seizures (HP:0002121) | 3.53178300 |
17 | Action tremor (HP:0002345) | 3.52965764 |
18 | Exercise-induced muscle cramps (HP:0003710) | 3.49685530 |
19 | Asymmetric septal hypertrophy (HP:0001670) | 3.46021480 |
20 | Generalized tonic-clonic seizures (HP:0002069) | 3.44248929 |
21 | Obstructive sleep apnea (HP:0002870) | 3.37136966 |
22 | Supranuclear gaze palsy (HP:0000605) | 3.29789682 |
23 | Difficulty running (HP:0009046) | 3.22121301 |
24 | Atonic seizures (HP:0010819) | 3.18648815 |
25 | Depression (HP:0000716) | 3.14351224 |
26 | Dialeptic seizures (HP:0011146) | 3.11785654 |
27 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.11577731 |
28 | EEG with generalized epileptiform discharges (HP:0011198) | 3.10841322 |
29 | Myopathic facies (HP:0002058) | 3.10387694 |
30 | Epileptiform EEG discharges (HP:0011182) | 3.10268243 |
31 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.03000896 |
32 | Increased variability in muscle fiber diameter (HP:0003557) | 3.02325920 |
33 | Abnormality of the calf musculature (HP:0001430) | 3.01797570 |
34 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.99512441 |
35 | Distal lower limb muscle weakness (HP:0009053) | 2.99219363 |
36 | Anxiety (HP:0000739) | 2.95298628 |
37 | Dysdiadochokinesis (HP:0002075) | 2.94917518 |
38 | Calf muscle hypertrophy (HP:0008981) | 2.87124954 |
39 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.82781301 |
40 | Postural instability (HP:0002172) | 2.82773389 |
41 | Abnormal atrioventricular conduction (HP:0005150) | 2.81759252 |
42 | Hypsarrhythmia (HP:0002521) | 2.80579179 |
43 | Myoglobinuria (HP:0002913) | 2.80557733 |
44 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.79905728 |
45 | Subaortic stenosis (HP:0001682) | 2.79905728 |
46 | Hemiparesis (HP:0001269) | 2.78117318 |
47 | Complement deficiency (HP:0004431) | 2.77914596 |
48 | Increased connective tissue (HP:0009025) | 2.76222876 |
49 | Rhabdomyolysis (HP:0003201) | 2.75281232 |
50 | Congenital stationary night blindness (HP:0007642) | 2.75268462 |
51 | EMG: neuropathic changes (HP:0003445) | 2.73365281 |
52 | Central scotoma (HP:0000603) | 2.70551965 |
53 | Truncal ataxia (HP:0002078) | 2.67466335 |
54 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.65930560 |
55 | Neck muscle weakness (HP:0000467) | 2.65851408 |
56 | Round ear (HP:0100830) | 2.65385365 |
57 | Poor eye contact (HP:0000817) | 2.64716672 |
58 | Neurofibrillary tangles (HP:0002185) | 2.64070567 |
59 | Ankle clonus (HP:0011448) | 2.63100883 |
60 | Hypoglycemic seizures (HP:0002173) | 2.63002997 |
61 | Abnormality of the lower motor neuron (HP:0002366) | 2.62679833 |
62 | Frequent falls (HP:0002359) | 2.60685099 |
63 | Gaze-evoked nystagmus (HP:0000640) | 2.54217594 |
64 | Impaired social interactions (HP:0000735) | 2.53702427 |
65 | Abnormal social behavior (HP:0012433) | 2.53702427 |
66 | Distal arthrogryposis (HP:0005684) | 2.52721593 |
67 | Genetic anticipation (HP:0003743) | 2.49516531 |
68 | Ketoacidosis (HP:0001993) | 2.49375336 |
69 | Atrioventricular block (HP:0001678) | 2.48694985 |
70 | Hyperkalemia (HP:0002153) | 2.48368308 |
71 | Exercise-induced myalgia (HP:0003738) | 2.48354376 |
72 | Torticollis (HP:0000473) | 2.48295391 |
73 | Dysmetria (HP:0001310) | 2.46159099 |
74 | Status epilepticus (HP:0002133) | 2.45868884 |
75 | Megalencephaly (HP:0001355) | 2.44861590 |
76 | Abnormality of the foot musculature (HP:0001436) | 2.43238692 |
77 | Impaired smooth pursuit (HP:0007772) | 2.42209079 |
78 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.41671976 |
79 | Hyperventilation (HP:0002883) | 2.40478382 |
80 | Foot dorsiflexor weakness (HP:0009027) | 2.39324423 |
81 | Rimmed vacuoles (HP:0003805) | 2.36241191 |
82 | Cerebral inclusion bodies (HP:0100314) | 2.35105228 |
83 | Prolonged QT interval (HP:0001657) | 2.35031231 |
84 | Fetal akinesia sequence (HP:0001989) | 2.32475152 |
85 | Focal dystonia (HP:0004373) | 2.30088100 |
86 | Abnormal eating behavior (HP:0100738) | 2.28912670 |
87 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.26986635 |
88 | Bradykinesia (HP:0002067) | 2.25779748 |
89 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.25376397 |
90 | Hemiplegia (HP:0002301) | 2.25177309 |
91 | Ventricular arrhythmia (HP:0004308) | 2.24897298 |
92 | Abnormality of macular pigmentation (HP:0008002) | 2.24896156 |
93 | Ventricular tachycardia (HP:0004756) | 2.24159648 |
94 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.23425218 |
95 | Agitation (HP:0000713) | 2.20849070 |
96 | Abnormal EKG (HP:0003115) | 2.18922713 |
97 | Excessive salivation (HP:0003781) | 2.18154223 |
98 | Drooling (HP:0002307) | 2.18154223 |
99 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.17622807 |
100 | Ventricular fibrillation (HP:0001663) | 2.17202559 |
101 | Muscle stiffness (HP:0003552) | 2.17182207 |
102 | Ulnar deviation of the wrist (HP:0003049) | 2.15780809 |
103 | Scanning speech (HP:0002168) | 2.15575298 |
104 | Broad-based gait (HP:0002136) | 2.12530210 |
105 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.11460388 |
106 | Bundle branch block (HP:0011710) | 2.10124057 |
107 | Lower limb amyotrophy (HP:0007210) | 2.09526407 |
108 | Pheochromocytoma (HP:0002666) | 2.09418469 |
109 | Distal lower limb amyotrophy (HP:0008944) | 2.09206188 |
110 | Hyperlipoproteinemia (HP:0010980) | 2.09166095 |
111 | Craniofacial dystonia (HP:0012179) | 2.08835356 |
112 | Atrial fibrillation (HP:0005110) | 2.08713645 |
113 | Oligomenorrhea (HP:0000876) | 2.07916394 |
114 | Rapidly progressive (HP:0003678) | 2.06778133 |
115 | Symptomatic seizures (HP:0011145) | 2.06642623 |
116 | Abnormality of complement system (HP:0005339) | 2.05608569 |
117 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.04356140 |
118 | Neoplasm of the heart (HP:0100544) | 2.04029511 |
119 | Myotonia (HP:0002486) | 2.03907711 |
120 | Deep venous thrombosis (HP:0002625) | 1.99692223 |
121 | Dysmetric saccades (HP:0000641) | 1.99450105 |
122 | Stereotypic behavior (HP:0000733) | 1.98696592 |
123 | Primary atrial arrhythmia (HP:0001692) | 1.98435147 |
124 | Intention tremor (HP:0002080) | 1.97768700 |
125 | Difficulty climbing stairs (HP:0003551) | 1.96480299 |
126 | Ketosis (HP:0001946) | 1.95187455 |
127 | Syncope (HP:0001279) | 1.95059656 |
128 | Hypoglycemic coma (HP:0001325) | 1.95028774 |
129 | Spastic gait (HP:0002064) | 1.94234483 |
130 | Decreased circulating renin level (HP:0003351) | 1.93821338 |
131 | Hypercortisolism (HP:0001578) | 1.93144276 |
132 | Aplasia of the phalanges of the hand (HP:0009802) | 1.92661534 |
133 | Aplasia involving bones of the extremities (HP:0009825) | 1.92661534 |
134 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.92661534 |
135 | Insomnia (HP:0100785) | 1.92135677 |
136 | Sleep apnea (HP:0010535) | 1.92110292 |
137 | Scotoma (HP:0000575) | 1.91091323 |
138 | Abnormality of binocular vision (HP:0011514) | 1.90727754 |
139 | Diplopia (HP:0000651) | 1.90727754 |
140 | Rigidity (HP:0002063) | 1.90354743 |
141 | Neuronal loss in central nervous system (HP:0002529) | 1.90316887 |
142 | Systemic lupus erythematosus (HP:0002725) | 1.89562107 |
143 | Amblyopia (HP:0000646) | 1.89432403 |
144 | Gowers sign (HP:0003391) | 1.88984800 |
145 | Scapular winging (HP:0003691) | 1.88485580 |
146 | Stridor (HP:0010307) | 1.86331287 |
147 | Blue irides (HP:0000635) | 1.86020480 |
148 | Supraventricular tachycardia (HP:0004755) | 1.84871351 |
149 | Limb ataxia (HP:0002070) | 1.83080111 |
150 | Impaired vibratory sensation (HP:0002495) | 1.82273176 |
151 | Dilated cardiomyopathy (HP:0001644) | 1.80823951 |
152 | Lower limb muscle weakness (HP:0007340) | 1.80338595 |
153 | Bulbar palsy (HP:0001283) | 1.79801262 |
154 | Joint hemorrhage (HP:0005261) | 1.79661466 |
155 | Late onset (HP:0003584) | 1.79479865 |
156 | Lipoatrophy (HP:0100578) | 1.79468469 |
157 | Supraventricular arrhythmia (HP:0005115) | 1.78714013 |
158 | Gait ataxia (HP:0002066) | 1.77818277 |
159 | Large for gestational age (HP:0001520) | 1.75852371 |
160 | Papilledema (HP:0001085) | 1.72666439 |
161 | Clonus (HP:0002169) | 1.71255309 |
162 | Urinary urgency (HP:0000012) | 1.71010147 |
163 | Retinal atrophy (HP:0001105) | 1.69679933 |
164 | Heart block (HP:0012722) | 1.69485041 |
165 | Hyperglycemia (HP:0003074) | 1.68935608 |
166 | Polyphagia (HP:0002591) | 1.68716159 |
167 | Neuroendocrine neoplasm (HP:0100634) | 1.68338155 |
168 | Global brain atrophy (HP:0002283) | 1.66198483 |
169 | Abnormal gallbladder physiology (HP:0012438) | 1.65773594 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 4.10578873 |
2 | EPHA4 | 4.10547227 |
3 | OBSCN | 3.75348629 |
4 | MAP3K9 | 2.93636183 |
5 | MAP3K4 | 2.62458249 |
6 | PRKD3 | 2.54845108 |
7 | TTN | 2.53615875 |
8 | DAPK2 | 2.51265238 |
9 | MINK1 | 2.43167871 |
10 | MARK1 | 2.29045948 |
11 | NTRK2 | 2.22548537 |
12 | PAK6 | 2.15075947 |
13 | INSRR | 2.13794622 |
14 | MAP2K7 | 1.97203287 |
15 | PHKG1 | 1.86786024 |
16 | PHKG2 | 1.86786024 |
17 | KSR2 | 1.84898622 |
18 | TNIK | 1.84495051 |
19 | MAP2K4 | 1.70741967 |
20 | STK38 | 1.63737587 |
21 | CAMKK1 | 1.63450835 |
22 | NTRK1 | 1.58892125 |
23 | PRPF4B | 1.53899140 |
24 | SIK2 | 1.47352643 |
25 | PINK1 | 1.45915605 |
26 | LMTK2 | 1.45602842 |
27 | MAP3K2 | 1.41910574 |
28 | CDK5 | 1.35228375 |
29 | RIPK1 | 1.33400836 |
30 | CAMKK2 | 1.28663601 |
31 | DAPK1 | 1.26759219 |
32 | PRKCG | 1.26278829 |
33 | KSR1 | 1.25132506 |
34 | EEF2K | 1.18644622 |
35 | SGK494 | 1.18461843 |
36 | SGK223 | 1.18461843 |
37 | ERN1 | 1.15863131 |
38 | SGK2 | 1.15779297 |
39 | SIK3 | 1.12344319 |
40 | MAPK13 | 1.10528298 |
41 | UHMK1 | 1.08457306 |
42 | GRK5 | 1.04322715 |
43 | CAMK1 | 1.04253309 |
44 | TYRO3 | 1.01093272 |
45 | SGK3 | 1.00628624 |
46 | MAP3K13 | 1.00477637 |
47 | WNK3 | 0.99836447 |
48 | PAK3 | 0.97402631 |
49 | PRKCH | 0.94765079 |
50 | SIK1 | 0.94669057 |
51 | TNK2 | 0.93254825 |
52 | CAMK2A | 0.92815414 |
53 | MAP3K1 | 0.92645728 |
54 | PRKAA2 | 0.89845586 |
55 | MARK2 | 0.86793076 |
56 | MAPK7 | 0.86790555 |
57 | ICK | 0.86470528 |
58 | MAPK15 | 0.85846157 |
59 | MAP3K11 | 0.85419434 |
60 | EPHA3 | 0.84148437 |
61 | DYRK1B | 0.83549501 |
62 | MAP3K6 | 0.83045415 |
63 | RET | 0.82696153 |
64 | RIPK4 | 0.82138386 |
65 | MAP2K3 | 0.81781894 |
66 | CDK19 | 0.81103786 |
67 | CDC42BPA | 0.80814765 |
68 | NME1 | 0.80615596 |
69 | FGFR2 | 0.80389511 |
70 | CAMK1G | 0.79336408 |
71 | EPHB1 | 0.79305265 |
72 | MAP3K7 | 0.78869027 |
73 | PIK3CG | 0.77243970 |
74 | MAP2K6 | 0.77217995 |
75 | FES | 0.74933472 |
76 | CASK | 0.73337873 |
77 | CAMK2D | 0.70629195 |
78 | CAMK2B | 0.69781048 |
79 | TAOK1 | 0.69222123 |
80 | PKN1 | 0.68435742 |
81 | ARAF | 0.68010308 |
82 | FER | 0.66835654 |
83 | SGK1 | 0.64906725 |
84 | FGFR4 | 0.63347977 |
85 | JAK2 | 0.63344086 |
86 | MAPK4 | 0.62900796 |
87 | PRKD1 | 0.62695160 |
88 | LATS2 | 0.60957548 |
89 | DMPK | 0.60531414 |
90 | CAMK4 | 0.60527862 |
91 | TAOK2 | 0.60346518 |
92 | CAMK2G | 0.58981136 |
93 | WNK4 | 0.58688345 |
94 | AKT3 | 0.58529424 |
95 | STK11 | 0.58321932 |
96 | FGFR3 | 0.57827591 |
97 | NEK1 | 0.57384246 |
98 | RPS6KA3 | 0.56414398 |
99 | WNK1 | 0.56347357 |
100 | PRKAA1 | 0.56315850 |
101 | * DYRK1A | 0.56082614 |
102 | TRPM7 | 0.55693976 |
103 | MAPK12 | 0.55659458 |
104 | CDK18 | 0.55189569 |
105 | JAK1 | 0.54961157 |
106 | RPS6KA2 | 0.54728403 |
107 | PRKCE | 0.53749790 |
108 | PDPK1 | 0.53433243 |
109 | CDK15 | 0.53057848 |
110 | TBK1 | 0.52839780 |
111 | CDK14 | 0.52772842 |
112 | MAPKAPK3 | 0.52069500 |
113 | MAP3K3 | 0.51737662 |
114 | PRKCZ | 0.51640989 |
115 | PNCK | 0.51241809 |
116 | PDK1 | 0.49524676 |
117 | MUSK | 0.49503602 |
118 | PTK2B | 0.47588179 |
119 | MAP2K1 | 0.47505545 |
120 | NEK6 | 0.47489977 |
121 | PLK2 | 0.47275133 |
122 | TRIB3 | 0.46931036 |
123 | MAPK10 | 0.46488705 |
124 | PRKD2 | 0.45822809 |
125 | IRAK2 | 0.45273586 |
126 | PDGFRA | 0.45177862 |
127 | CDK11A | 0.44356829 |
128 | HIPK2 | 0.44133277 |
129 | PRKACG | 0.42915354 |
130 | PRKACA | 0.42401965 |
131 | PIK3CA | 0.41278907 |
132 | PDK2 | 0.40159645 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.17077609 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.85119987 |
3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.63050480 |
4 | Insulin secretion_Homo sapiens_hsa04911 | 2.61530175 |
5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.48106167 |
6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.47020109 |
7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.35755904 |
8 | Morphine addiction_Homo sapiens_hsa05032 | 2.25980252 |
9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.15102859 |
10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.11001783 |
11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.05462388 |
12 | Long-term potentiation_Homo sapiens_hsa04720 | 1.99521602 |
13 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.96325308 |
14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.94864521 |
15 | Salivary secretion_Homo sapiens_hsa04970 | 1.89216488 |
16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.80538949 |
17 | Taste transduction_Homo sapiens_hsa04742 | 1.74225245 |
18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.71555130 |
19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.71445910 |
20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.63691318 |
21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.60591748 |
22 | Renin secretion_Homo sapiens_hsa04924 | 1.56354575 |
23 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.55311482 |
24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.54473931 |
25 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.47626203 |
26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.45269591 |
27 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.44428417 |
28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.40688008 |
29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.40254309 |
30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.33747678 |
31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29976754 |
32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.27819577 |
33 | Long-term depression_Homo sapiens_hsa04730 | 1.19253771 |
34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.18876390 |
35 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.18185676 |
36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.17374453 |
37 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.10993115 |
38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.10591759 |
39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.09264650 |
40 | Bile secretion_Homo sapiens_hsa04976 | 1.08499687 |
41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.07152224 |
42 | * Circadian rhythm_Homo sapiens_hsa04710 | 1.06981154 |
43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.03979106 |
44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01440355 |
45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.99555356 |
46 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.96867294 |
47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96553016 |
48 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.96299684 |
49 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.95811100 |
50 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95575552 |
51 | Gap junction_Homo sapiens_hsa04540 | 0.95200855 |
52 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92455430 |
53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89343366 |
54 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.89169573 |
55 | Phototransduction_Homo sapiens_hsa04744 | 0.89034858 |
56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87559908 |
57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.85062394 |
58 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.84434210 |
59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.83907735 |
60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.83506499 |
61 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.82287866 |
62 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80658636 |
63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80617376 |
64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.77902415 |
65 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.74057805 |
66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70400262 |
67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.69827589 |
68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68965730 |
69 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.68937426 |
70 | Melanogenesis_Homo sapiens_hsa04916 | 0.66026586 |
71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64955415 |
72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63194199 |
73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62205641 |
74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.60421769 |
75 | Glioma_Homo sapiens_hsa05214 | 0.60145842 |
76 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.58907334 |
77 | ABC transporters_Homo sapiens_hsa02010 | 0.58758648 |
78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57948643 |
79 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.57135240 |
80 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.56780463 |
81 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.56532252 |
82 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.55202954 |
83 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54789570 |
84 | Axon guidance_Homo sapiens_hsa04360 | 0.54290712 |
85 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.53781198 |
86 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53683712 |
87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52946305 |
88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51832932 |
89 | Prion diseases_Homo sapiens_hsa05020 | 0.51427392 |
90 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.49383446 |
91 | Retinol metabolism_Homo sapiens_hsa00830 | 0.49341477 |
92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47521840 |
93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47504979 |
94 | Carbon metabolism_Homo sapiens_hsa01200 | 0.47264751 |
95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47150365 |
96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47015176 |
97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46894466 |
98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45539473 |
99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45496904 |
100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43876154 |
101 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43465415 |
102 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41147495 |
103 | Insulin resistance_Homo sapiens_hsa04931 | 0.39708668 |
104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39697250 |
105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39168010 |
106 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38754449 |
107 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.38194930 |
108 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37915648 |
109 | Tight junction_Homo sapiens_hsa04530 | 0.37024732 |
110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36528710 |
111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35819422 |
112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35590209 |
113 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35332240 |
114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33760516 |
115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32336980 |
116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.32070018 |
117 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.30935822 |
118 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.29265671 |